SOL Capital Management CO reduced its position in Monsanto Co. (NYSE:MON) by 5.4% during the second quarter, Holdings Channel reports. The fund owned 4,360 shares of the company’s stock after selling 250 shares during the period. SOL Capital Management CO’s holdings in Monsanto were worth $451,000 as of its most recent filing with the SEC.
Other large investors have also recently made changes to their positions in the company. Carnick & Kubik LLC purchased a new stake in shares of Monsanto during the first quarter worth about $130,000. Bartlett & Co. LLC increased its stake in shares of Monsanto by 10.6% in the second quarter. Bartlett & Co. LLC now owns 1,402 shares of the company’s stock worth $145,000 after buying an additional 134 shares during the last quarter. Quadrant Capital Group LLC increased its stake in shares of Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock worth $184,000 after buying an additional 16 shares during the last quarter. Palladium Partners LLC purchased a new stake in shares of Monsanto during the second quarter worth about $205,000. Finally, First Quadrant L P CA increased its stake in shares of Monsanto by 42.9% in the second quarter. First Quadrant L P CA now owns 2,000 shares of the company’s stock worth $207,000 after buying an additional 600 shares during the last quarter. 79.02% of the stock is currently owned by hedge funds and other institutional investors.
Monsanto Co. (NYSE:MON) traded down 0.42% during trading on Friday, hitting $102.11. The stock had a trading volume of 3,212,435 shares. The stock’s 50-day moving average is $104.53 and its 200-day moving average is $101.70. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26. The stock has a market capitalization of $44.69 billion, a PE ratio of 34.17 and a beta of 1.19.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. During the same quarter last year, the firm posted ($0.19) earnings per share. The business’s revenue was up 8.8% compared to the same quarter last year. On average, analysts predict that Monsanto Co. will post $4.89 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, October 7th will be paid a $0.54 dividend. The ex-dividend date is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a yield of 2.11%. Monsanto’s payout ratio is 71.05%.
A number of equities research analysts have recently issued reports on MON shares. Vetr downgraded shares of Monsanto from a “strong-buy” rating to a “buy” rating and set a $116.47 price target on the stock. in a report on Thursday, July 14th. Credit Agricole SA reaffirmed a “buy” rating on shares of Monsanto in a research note on Saturday, July 2nd. Deutsche Bank AG reaffirmed a “buy” rating and issued a $118.00 target price on shares of Monsanto in a research note on Thursday, June 30th. Jefferies Group reaffirmed a “buy” rating on shares of Monsanto in a research note on Wednesday, June 29th. Finally, Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and raised their target price for the company from $106.93 to $130.00 in a research note on Monday, August 8th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $114.65.
In other Monsanto news, Director Charles S. Mcmillan bought 3,500 shares of Monsanto stock in a transaction on Monday, October 10th. The shares were acquired at an average price of $103.23 per share, for a total transaction of $361,305.00. Following the completion of the purchase, the director now directly owns 64,009 shares in the company, valued at approximately $6,607,649.07. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Steven Mizell sold 310 shares of the stock in a transaction on Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The disclosure for this sale can be found here. 0.88% of the stock is owned by company insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.